Company intelligence / Profile preview

Alba Health

Ownership: Private
Employees: ~21
Development stage: Other

Overview

Alba Health offers a non-invasive at-home gut microbiome test for children aged 0–13 years. The service includes detailed reports on the child's gut flora with actionable insights to improve immune system development, metabolism, and cognition. Customers receive personalized nutrition plans and one-on-one coaching based on AI-driven analysis of the results. The company collaborates with leading academic cohorts such as HELMi at the University of Helsinki to advance research in early-life microbiomes

Therapeutic areas: Immunology
Modalities: Diagnostic test (gut microbiome analysis)Digital health support (AI-driven recommendations)
Industry: Molecular Diagnostics

Partnerships

University of Helsinki / HELMi Cohort study

Beyond the preview

Go deeper on Alba Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alba Health.

Explore the full profile